Clindamycin Phosphate 1.2% and Tretinoin 0.025% Gel

DRUG2 trials

Sponsors

Massachusetts General Hospital, Callender Center for Clinical Research

Conditions

AcneRosacea

Phase 2

Safety and Efficacy Study of Clindamycin Phosphate 1.2% and Tretinoin 0.025% Gel to Treat Rosacea

CompletedNCT00823901

Massachusetts General HospitalRosacea

Start: 2009-02-28End: 2010-10-31Updated: 2012-06-25

Phase 4

Efficacy & Safety of Clindamycin and Tretinoin in Acne

Callender Center for Clinical ResearchAcne

Start: 2009-11-30End: 2010-04-30Target: 30Updated: 2010-05-20